SCHEMBL4609004

SCHEMBL4609004

CCCCCC/C=C/P(=O)(c1ccccc1)c1ccccc1

nearest known ligand 0.50

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
SOAT2 O75908 1/20 0.46
SOAT1 P35610 1/20 0.46
FAAH O00519 5/20 0.45
CES1 P23141 2/20 0.45
EPHX2 P34913 2/20 0.43
CNR1 P21554 1/20 0.42
CNR2 P34972 1/20 0.42
MEN1 O00255 1/20 0.41
KMT2A Q03164 1/20 0.41
NPSR1 Q6W5P4 1/20 0.41
TP53 P04637 1/20 0.40
CYP3A4 P08684 1/20 0.40
MAPT P10636 1/20 0.40
TSHR P16473 1/20 0.40
TRPV1 Q8NER1 1/20 0.40
DUSP3 P51452 1/20 0.40
PTPN7 P35236 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4609010 1.00 SOAT2 (0.46) SOAT2SOAT1FAAHCES1EPHX2
SCHEMBL21518324 0.94 FAAH (0.44) SOAT2SOAT1FAAHCES1EPHX2
SCHEMBL28328347 0.93 CYP3A4 (0.45) SOAT2SOAT1FAAHCES1MEN1
SCHEMBL4878268 0.84 SOAT2 (0.47) SOAT2SOAT1FAAHCES1EPHX2
SCHEMBL31590883 0.84 SOAT2 (0.47) SOAT2SOAT1FAAHCES1EPHX2
SCHEMBL4878263 0.84 SOAT2 (0.47) SOAT2SOAT1FAAHCES1EPHX2
SCHEMBL4606338 0.80 AOX1 (0.44) SOAT2SOAT1FAAHCES1EPHX2
SCHEMBL4606349 0.80 AOX1 (0.44) SOAT2SOAT1FAAHCES1EPHX2
SCHEMBL18486579 0.78 MEN1 (0.41) MEN1KMT2ANPSR1MAPTTSHR
SCHEMBL18486575 0.78 MEN1 (0.41) MEN1KMT2ANPSR1MAPTTSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1369422-B1 PROCESS FOR PREPARATION OF ALKENYLPHOSPHINE OXIDES OR ALKENYLPHOSPHINIC ACID ESTERS JAPAN SCIENCE & TECH AGENCY (JP) 2008-07-23 EP disclosed
US-7135583-B2 Process for preparation of alkenylphosphine oxides or alkenylphosphinic esters JAPAN SCIENCE AND TECHNOLOGY CORPORATION (JP) 2006-11-14 US disclosed
US-20040059146-A1 Process for preparation of alkenylphosphine oxides or alkenylphosphinic esters JAPAN SCIENCE AND TECHNOLOGY CORPORATION (JP) 2004-03-25 US disclosed
EP-1369422-A1 PROCESS FOR PREPARATION OF ALKENYLPHOSPHINE OXIDES OR ALKENYLPHOSPHINIC ACID ESTERS Japan Science and Technology Corporation (JP) 2003-12-10 EP disclosed
JP-2002241386-A METHOD FOR PRODUCING ALKENYLPHOSPHINE OXIDES JAPAN SCIENCE & TECHNOLOGY CORP 2002-08-28 JP disclosed
EP-0794190-B1 Method of producing alkenylphosphine oxide or bis (alkenylphosphine oxide) NAT INST OF ADVANCED IND SCIEN (JP) 2002-04-24 EP disclosed
EP-0794190-A1 Method of producing alkenylphosphine oxide or bis (alkenylphosphine oxide) DIRECTOR-GENERAL OF THE AGENCY OF INDUSTRIAL SCIENCE AND TECHNOLOGY (JP) 1997-09-10 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040059146-A1 Process for preparation of alkenylphosphine oxides or alkenylphosphinic esters PHOSPHO1, AGPS, AGPAT5 SOAT2 132/4885SOAT1 116/4885FAAH 1575/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.